
### [NCIT:C27949](http://purl.obolibrary.org/obo/NCIT_C27949)
**Label:** Metaplastic Carcinoma

**Subclasses:** [NCIT:C8904](http://purl.obolibrary.org/obo/NCIT_C8904) (Stage I Squamous Cell Carcinoma of the Bladder), [NCIT:C8905](http://purl.obolibrary.org/obo/NCIT_C8905) (Stage III Bladder Squamous Cell Carcinoma), [NCIT:C8902](http://purl.obolibrary.org/obo/NCIT_C8902) (Recurrent Bladder Squamous Cell Carcinoma), [NCIT:C8903](http://purl.obolibrary.org/obo/NCIT_C8903) (Stage 0 Bladder Squamous Cell Carcinoma), [NCIT:C116316](http://purl.obolibrary.org/obo/NCIT_C116316) (Intestinal-Type Sinonasal Adenocarcinoma), [NCIT:C4994](http://purl.obolibrary.org/obo/NCIT_C4994) (Stage II Bladder Squamous Cell Carcinoma), [NCIT:C4126](http://purl.obolibrary.org/obo/NCIT_C4126) (Intestinal-Type Adenocarcinoma), [NCIT:C136710](http://purl.obolibrary.org/obo/NCIT_C136710) (Lung Enteric Adenocarcinoma), [NCIT:C7027](http://purl.obolibrary.org/obo/NCIT_C7027) (Barrett Adenocarcinoma), [NCIT:C9157](http://purl.obolibrary.org/obo/NCIT_C9157) (Gastric Intestinal-Type Adenocarcinoma), [NCIT:C27768](http://purl.obolibrary.org/obo/NCIT_C27768) (Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma), [NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type), [NCIT:C4031](http://purl.obolibrary.org/obo/NCIT_C4031) (Bladder Squamous Cell Carcinoma), [NCIT:C43604](http://purl.obolibrary.org/obo/NCIT_C43604) (Gallbladder Adenocarcinoma, Intestinal-Type), [NCIT:C39833](http://purl.obolibrary.org/obo/NCIT_C39833) (Schistosoma Hematobium-Related Bladder Verrucous Carcinoma), [NCIT:C39832](http://purl.obolibrary.org/obo/NCIT_C39832) (Bladder Verrucous Carcinoma), [NCIT:C128166](http://purl.obolibrary.org/obo/NCIT_C128166) (Vulvar Adenocarcinoma, Intestinal-Type), [NCIT:C8906](http://purl.obolibrary.org/obo/NCIT_C8906) (Stage IV Bladder Squamous Cell Carcinoma), [NCIT:C39845](http://purl.obolibrary.org/obo/NCIT_C39845) (Bladder Urachal Squamous Cell Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.99%
- [NCIT:C8391](http://purl.obolibrary.org/obo/NCIT_C8391) (Squamous Metaplasia of Bladder) 52.08%
- [NCIT:C8360](http://purl.obolibrary.org/obo/NCIT_C8360) (Intestinal Metaplasia) 52.08%
- [NCIT:C60749](http://purl.obolibrary.org/obo/NCIT_C60749) (Metaplasia of Malignant Cells Present) 52.08%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 52.08%
- [NCIT:C36679](http://purl.obolibrary.org/obo/NCIT_C36679) (HRAS Gene Amplification) 52.08%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 52.08%
- [NCIT:C36636](http://purl.obolibrary.org/obo/NCIT_C36636) (Loss of Chromosome 9p) 52.08%
- [NCIT:C36502](http://purl.obolibrary.org/obo/NCIT_C36502) (Loss of Chromosome 3p) 52.08%
- [NCIT:C36497](http://purl.obolibrary.org/obo/NCIT_C36497) (Loss of Chromosome 13q) 52.08%
- [NCIT:C36488](http://purl.obolibrary.org/obo/NCIT_C36488) (Gain of Chromosome 8q) 52.08%
- [NCIT:C36482](http://purl.obolibrary.org/obo/NCIT_C36482) (Gain of Chromosome 1q) 52.08%
- [NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q) 52.08%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 52.08%
- [NCIT:C2999](http://purl.obolibrary.org/obo/NCIT_C2999) (Dysuria) 52.08%


